Trial · NCT01121991
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Local tolerability of injections | General disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 5 | 52 | |
| other | Abdominal distension | Gastrointestinal disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Constipation | Gastrointestinal disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 2 | 52 | |
| other | Diarrhea | Gastrointestinal disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 2 | 52 | |
| other | Flatulence | Gastrointestinal disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Fatigue | General disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 2 | 52 | |
| other | Injection site pain | General disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Vulvovaginal mycotic infection | Infections and infestations | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Post procedural nausea | Injury, poisoning and procedural complications | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Procedural pain | Injury, poisoning and procedural complications | Recombinant Human-Luteinizing Hormone (Luveris) | 2 | 52 | |
| other | Procedural vomiting | Injury, poisoning and procedural complications | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Headache | Nervous system disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Loss of consciousness | Nervous system disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Intra-uterine death | Pregnancy, puerperium and perinatal conditions | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Anxiety | Psychiatric disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Dysuria | Renal and urinary disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Genital pruritus female | Reproductive system and breast disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| other | Ovarian Hyperstimulation Syndrome | Reproductive system and breast disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 3 | 52 | |
| other | Ecchymosis | Skin and subcutaneous tissue disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 | |
| serious | Abdominal pain | Gastrointestinal disorders | Recombinant Human-Luteinizing Hormone (Luveris) | 1 | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01121991/events